For most people with nail fungus, oral terbinafine (sold as Lamisil) is worth the risk. It remains the most effective treatment available, with mycological cure rates around 70% for toenail infections, and the serious side effects that worry people most, particularly liver damage, are rare. But “rare” isn’t “zero,” and the drug does come with a list of common, milder side effects that affect a meaningful number of users. Whether the tradeoff makes sense depends on how severe your infection is, how healthy your liver is, and how much the fungus bothers you.
How Well Terbinafine Actually Works
Terbinafine is the first-line oral treatment for nail fungus for a reason: nothing else clears infections as reliably. For toenails, the standard course is one pill daily for 12 weeks. For fingernails, it’s six weeks. You won’t see results immediately because nails grow slowly. A toenail takes six to nine months to fully replace itself, so you’re waiting for a healthy nail to gradually push out the damaged one.
The alternatives tell the story of why terbinafine dominates. Topical treatments like efinaconazole and tavaborole require daily application for 48 weeks on toenails, nearly a full year, and their cure rates are significantly lower. Other oral options exist, but terbinafine consistently outperforms them in head-to-head comparisons for the most common type of nail fungus.
One frustration: even after a successful course, the fungus comes back in a substantial number of people. Recurrence rates vary across studies, but reinfection within a few years is common enough that you should think of nail fungus as a condition you manage rather than permanently eliminate. Keeping nails short, wearing breathable shoes, and treating athlete’s foot promptly all reduce your odds of a repeat.
The Side Effects Most People Experience
The most common side effects are gastrointestinal. In controlled trials, about 5.6% of patients on terbinafine reported diarrhea (compared to 2.9% on placebo), 4.3% had indigestion, 2.6% had nausea, and 2.4% had abdominal pain. These numbers mean the drug causes noticeable gut symptoms in roughly 1 in 20 to 1 in 40 users beyond what you’d expect from a sugar pill. For most people, these are annoying but manageable.
Taste disturbance is the side effect that catches people off guard. About 2.8% of patients in trials reported changes in taste, compared to just 0.7% on placebo. This can range from a metallic flavor to a partial or complete loss of taste. In most cases, taste returns after stopping the medication, but recovery can take weeks to months, and in rare cases it lingers. Loss of smell has also been reported. If you notice changes in taste or smell during treatment, that’s worth flagging to your prescriber right away.
Headache and skin rash round out the more common complaints. None of these are dangerous, but they can make 12 weeks feel long.
The Liver Risk in Perspective
Liver toxicity is the reason people search “is Lamisil worth the risk,” and it deserves a clear-eyed look. Terbinafine can cause liver enzyme elevations, which show up as abnormal numbers on a blood test. In clinical trials, liver enzyme abnormalities were listed among the adverse events occurring in more than 2% of treated patients. Most of these elevations are mild and reversible.
The fear, though, is severe liver injury: the kind that leads to liver failure or transplant. This does happen, but it is genuinely rare, estimated at roughly 1 in 50,000 to 1 in 120,000 prescriptions in pharmacovigilance data. To put that in perspective, your risk of a serious car accident on any given cross-country road trip is in a similar ballpark. It’s not zero, but it’s low enough that regulators and dermatologists consider the drug safe for the general population.
The standard safety protocol is straightforward. Your prescriber should order a blood test to check liver function before you start and may repeat it during the course. If your baseline liver enzymes are already elevated, or if you have active liver disease, terbinafine is not appropriate for you. Symptoms of liver trouble include unusual fatigue, dark urine, pale stools, yellowing of the skin or eyes, and persistent nausea. These warrant stopping the medication immediately.
Who Should Avoid It
Terbinafine is not recommended for people with existing liver disease, and that’s a hard line. It’s also not recommended for people with significant kidney impairment, specifically those with a creatinine clearance of 50 mL/min or below. If you have chronic kidney disease, your body can’t clear the drug efficiently, which raises the risk of side effects across the board.
People taking medications that are processed by the same liver enzymes should also proceed cautiously. Terbinafine interacts with several common drugs, and your prescriber needs a full medication list before writing the prescription. If you’re otherwise healthy, have normal liver function, and aren’t on conflicting medications, you’re in the group where the risk-benefit math is most favorable.
What the Alternatives Look Like
If the risks of oral terbinafine feel too high for your comfort, the main alternatives are topical antifungals and other oral medications. Topical options include ciclopirox (applied daily for 48 weeks on toenails), efinaconazole, and tavaborole. These avoid systemic side effects almost entirely because very little of the drug enters your bloodstream. The tradeoff is lower efficacy and a much longer treatment timeline. For mild infections that haven’t spread to the nail root, topicals can be reasonable.
Other oral antifungals like itraconazole and fluconazole are alternatives, though they carry their own liver risks and drug interaction profiles. Itraconazole for toenails is typically taken daily for 12 weeks or in pulse cycles. Fluconazole is dosed once weekly until the nail grows out completely, which can take many months. Neither matches terbinafine’s cure rates for the most common fungal species.
Doing nothing is also an option. Nail fungus is not dangerous in most healthy people. It’s a cosmetic and comfort issue. If you have diabetes or a weakened immune system, untreated nail fungus carries more risk because it can serve as an entry point for bacterial infections. But if you’re healthy and the appearance doesn’t bother you, watchful waiting is legitimate.
Making the Decision
The practical calculation comes down to this: terbinafine offers the best chance of clearing nail fungus in a relatively short treatment window, with common side effects that are mostly mild and a serious liver risk that is statistically very small. Generic terbinafine is also inexpensive compared to newer topical treatments, which can cost hundreds of dollars for a full course.
The people who benefit most clearly are those with moderate to severe toenail fungus, normal liver and kidney function, and no problematic drug interactions. If your infection involves multiple nails or has reached the nail matrix (the growth center near the cuticle), topical treatments alone are unlikely to work, making the oral route more justified. For a single nail with mild discoloration near the tip, starting with a topical or simply monitoring may be the smarter first move.